Clinical Trials for Unresectable Breast Carcinoma

Find clinical trials for unresectable breast carcinoma. Discover research opportunities and treatment options in your area.

7 Active Trials Found

Showing 7 trials on this page

Page 1 of 1

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

NCT ID: NCT07137416

This clinical trial is studying a new combination of two anti-cancer drugs, called Pidnarulex and trastuzumab deruxtecan, to see if it is safe and what dose works best for treating certain types of...

Not yet recruiting

Phase: PHASE1 Type: interventional

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

NCT ID: NCT06827236

This clinical trial is studying a new combination treatment for patients with advanced breast cancer, specifically looking at two investigational drugs called BNT323 and BNT327. The goal is to find...

Recruiting

Phase: PHASE1 Type: interventional Locations: San Antonio, Texas, United States, Port Saint Lucie, Florida, United States +5 more

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

NCT ID: NCT04704661

The DASH Trial is a clinical study exploring the safety and effectiveness of two anti-cancer drugs, DS-8201a and AZD6738, for patients with various types of advanced solid tumors that express the H...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bethesda, Maryland, United States, Saint Louis, Missouri, United States +22 more

Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

NCT ID: NCT06714617

This clinical trial is investigating a new treatment called BL-M17D1 for patients with advanced or metastatic solid tumors that have a specific protein called HER2. The study aims to evaluate how s...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Indianapolis, Indiana, United States +10 more

In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors

NCT ID: NCT04616248

This clinical trial is studying a new treatment approach for patients with certain types of advanced cancer that cannot be surgically removed. The treatment combines a medication called CDX-301, ra...

Recruiting

Phase: PHASE1 Type: interventional Locations: Buffalo, New York, United States, Los Angeles, California, United States +1 more

Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer

NCT ID: NCT03971409

This clinical trial is investigating how well a combination of three different treatments works for patients with stage IV or unresectable recurrent triple-negative breast cancer. The study focuses...

Recruiting

Phase: PHASE2 Type: interventional Locations: Rochester, Minnesota, United States, Houston, Texas, United States +12 more

The COMPASSION Study

NCT ID: NCT06507930

The COMPASSION Study is a research project designed to learn more about the experience of patients with advanced breast cancer who are receiving care at home through hospice services. The study aim...

Recruiting

Phase: NA Type: interventional Locations: Boston, Massachusetts, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions